Current concepts and approach to ventriculitis

Infectious Diseases in Clinical Practice

Volumn 16, Issue 2, 2008, Pages 100-104

  Agrawal, Amit ^a   Cincu, Rafael ^b   Timothy, Jake ^c  

^a DATTA MEGHE INSTITUTE OF MEDICAL SCIENCES   (India)

^b HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^c LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEPHALOSPORIN; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; IMMUNOGLOBULIN G; POLYMYXIN B; RIFAMPICIN; TEICOPLANIN; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; BRAIN VENTRICULITIS; CEREBROSPINAL FLUID; COMPUTER ASSISTED TOMOGRAPHY; ENTEROBACTER; HUMAN; IMMUNOCOMPROMISED PATIENT; INJURY; MENINGITIS; MINIMUM INHIBITORY CONCENTRATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PSEUDOMONAS AERUGINOSA; REVIEW; SHUNT INFECTION;

EID: 40949111972     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: 10.1097/IPC.0b013e318142ce2c     Document Type: Review

References (77)

1. Bakshi R, Kinkel P, Mechtler L, et al. Cerebral ventricular empyema associated with severe adult pyogenic meningitis: computed tomography findings. Clin Neurol Neurosurg. 1997;99:252-255.
2. Barloon TJ, Yuh WT, Knepper LE, et al. Cerebral ventriculitis: MR findings. J Comput Assist Tomogr. 1990;14:272-275.
3. Bodino J, Lylyk P, Del Valle M, et al. Computed tomography in purulent meningitis. Am J Dis Child. 1982;136:495-501.
4. Fukui MB, Williams RL, Mudigonda S. CT and MR imaging features of pyogenic ventriculitis. AJNR Am J Neuroradiol. 2001;22:1510-1516.
5. Wormser G, Strashun A. Ventriculitis complicating gram negative meninigitis in an adult: diagnosis by radioisotope brain scanning and computerized tomography. Mt Sinai J Med. 1980;47:575-578.
6. Vachon L, Mikity V. Computed tomography and ultrasound in purulent ventriculitis. J Ultrasound Med. 1987;6:269-271.
7. Cabeça HLS, Gomes HR, Machado L dos R, et al. Dosage of lactate in the cerebrospinal fluid in infectious diseases of the central nervous system. Arq Neuropsiquiatr. 2001;59(4):843-848.
8. Sundbarg G, Kjallquest A, Lundberg N, et al. Complications due to prolonged ventricular fluid pressure recording in clinical practice. In: Brock M, Dietz H, eds. Intracranial Pressure I: Experimental and Clinical Aspects - International Symposium on Intracranial Pressure, Hannover, 1972. Berlin: Springer-Verlag; 1972:348-351.
9. Lozier AP, Sciacca RR, Romagnoli MF, et al. Ventriculostomy-related infections: a critical review of the literature. Neurosurgery. 2002;51:170-182.
10. Sundbarg G, Nordstrom CH, Soderstrom S. Complications due to prolonged ventricular fluid pressure recording. Br J Neurosurg. 1988;2:485-495.
11. Lyke KE, Obasanjo OO, Williams MA, et al. Ventriculitis complicating use of intraventricular catheters in adult neurosurgical patients. Clin Infect Dis. 2001;33:2028-2033.
12. Holloway KL, Barnes T, Choi S, et al. Ventriculostomy infections: the effects of monitoring duration and catheter exchange in 584 patients. J Neurosurg. 1996;85:419-426.
13. Wong GKC, Poon WS, Wai S, et al. Failure of regular external ventricular drain exchange to reduce cerebrospinal fluid infection: result of a randomised controlled trial. J Neurol Neurosurg Psychiatry. 2002;73:759-761.
14. Black PM, Levine BW, Picard EH, et al. Asymmetrical hydrocephalus following ventriculitis from rupture of a thalamic abscess. Surg Neurol. 1983;19:524-527.
15. Maeda K, Sanada M, Kawai H, et al. Pyogenic ventriculitis with ruptured brain abscess. Intern Med. 2006;45(13):835-836.
16. de Silva T, Raychaudhuri M, Poulton M, et al. Ventriculitis and hydrocephalus: an unusual presentation of toxoplasmosis in an adult with human immunodeficiency virus. J Neurol Neurosurg Psychiatry. 2005;76:1074.
17. Janowicz DM, Johnson RM, Gupta SK. Successful treatment of CMV ventriculitis immune reconstitution syndrome. J Neurol Neurosurg Psychiatry. 2005;76:891-892.
18. Lorberboym M, Wallach F, Estok L, et al. Rapid differential diagnosis of cerebral toxoplasmosis and primary central nervous system lymphoma by thallium-201 SPECT. J Nucl Med. 1996;37:1150-1154.
19. Kim DK, Uttley D, Bell BA, et al. Comparison of rates of infection of two methods of emergency ventricular drainage. J Neurol Neurosurg Psychiatry. 1995;58:444-446.
20. Mayhall CG, Archer NH, Lamb VA, et al. Ventriculostomy-related infections: a prospective epidemiologic study. N Engl J Med. 1984;310:553-559.
21. Kaiser A, McGee Z. Aminoglycoside therapy of gram negative bacillary meningitis. N Engl J Med. 1975;293:1215-1220.
22. Mangi R, Holstein L, Andriole V. Treatment of gram negative bacillary meningitis with intrathecal gentamicin. Yale J Biol Med. 1977;50:31-41.
23. Durand M, Calderwood S, Weber D, et al. Acute bacterial meningitis in adults: a review of 493 episodes. N Engl J Med. 1993;328:21-28.
24. Pfausler B, Spiss H, Beer R, et al. Treatment of staphylococcal ventriculitis associated with external cerebrospinal fluid drains: a prospective randomized trial of intravenous compared with intraventricular vancomycin therapy. J Neurosurg. 2003;98(5):1040-1044.
25. Hand WL, Sanford JP. Posttraumatic bacterial meningitis. Ann Intern Med. 1970;72(6):869-874.
26. Dallacasa P, Dappozzo A, Galassi E, et al. Cerebrospinal fluid shunt infections in infants. Child's Nerv Syst. 1995;11:643-649.
27. Galassi E, Dallacasa P, Dappozzo A. Cerebrospinal shunt infections in infants. Child's Nerv Syst. 1996;12(5):231.
28. Anderson EJ, Yogev R. A rational approach to the management of ventricular shunt infections. Pediatr Infect Dis J. 2005;24:557-558.
29. Udani V, Udani S, Merani R, et al. Unrecognised ventriculitis/meningitis presenting as hydrocephalus in infancy. Indian Pediatr. 2003;40:870-873.
30. Aicardi J. Infectious diseases. In: Aicardi J, Bax M, Gillberg C, et al, eds. Diseases of the Nervous System in Childhood. 2nd ed. London: Mac Keith Press; 1998:373-437.
31. Carey CM, Tullous MW, Walker ML. Hydrocephalus: etiology, pathologic effects, diagnosis and natural history. In: Cheek WR, Marlin AE, McLone DG, et al, eds. Pediatric Neurosurgery. Surgery of the Developing Nervous System. 3rd ed. Philadelphia, PA: WB Saunders Co; 1994:185-201.
32. Rahal JJ, Hyams P, Simberkoff M, et al. Combined intrathecal and intramuscular gentamicin for gram negative meningitis: pharmacologic study of 21 patients. N Engl J Med. 1974;290:1394-1398.
33. Wiswell TE, Baumgart S, Gannon CM, et al. No lumbar puncture in the evaluation for early neonatal sepsis: will meningitis be missed? Pediatrics. 1995;95:803-806.
34. Schroeder S, Stuerenburg HJ, Escherich F, et al. Lysozyme in ventriculitis: a marker for diagnosis and disease progression. J Neurol Neurosurg Psychiatry. 2000;69:696-697.
35. Farhat CK, Soares CS, Sokolowski W, et al. Emprego da dosagem do lactato liquórico como método auxiliary no diagnóstico diferencial das meningites. J Pediatr (Rio J). 1982;52:406-410.
36. Firth G, Rees J, McKeran RO. The value of measurement of cerebrospinal fluid levels of lysozyme in the diagnosis of neurological disease. J Neurol Neurosurg Psychiatry. 1985;48:709-712.
37. Lee E, Robinson M, Thong M, et al. Intraventricular chemotherapy in neonatal meningitis. J Pediatr. 1977;91:991-995.
38. Zimmerman R, Patel S, Bilaniuk L. Demonstration of purulent bacterial intracranial infections by computed tomography. AJR Am J Roentgenol. 1976;127:155-165.
39. Lee H. Unilateral pyogenic ventriculitis. J Nucl Med. 1977;18:403.
40. Fulmer L, Sfakianakis G. Cerebral ventricle visualization during brain scanning with 99m tc-pertechnetate. J Nucl Med. 1974;15:202-204.
41. Berman P, Banker B. Neonatal meningitis: a clinical and pathological study of 29 cases. Pediatrics. 1966;38:6-24.
42. Pfausler B, Spiss H, Dittrich P, et al. Concentrations of fosfomycin in the cerebrospinal fluid of neurointensive care patients with ventriculostomy-associated ventriculitis. J Antimicrob Chemother. 2004;53:848-852.
43. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004;39:1267-1284.
44. Whitley RJ, Jacobson MA, Freidber DN, et al. Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. Arch Intern Med. 1998;158:957-969.
45. Tunkel AR, Kaufman BA. Cerebrospinal fluid shunt infections. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 6th ed. Philadelphia: Elsevier Science; 2004:1126-1132.
46. Bayston R, Hart CA, Barnicoat M. Intraventricular vancomycin in the treatment of ventriculitis associated with cerebrospinal fluid shunting and drainage. J Neurol Neurosurg Psychiatry. 1987;50(11):1419-1423.
47. Wen DY, Bottini AG, Hall WA, et al. The intraventricular use of antibiotics. Neurosurg Clin North Am. 1992;3:343-354.
48. Fong IW, Tomkins KB. Review of Pseudomonas aeruginosa meningitis with special emphasis on treatment with ceftazidime. Rev Infect Dis. 1985;7:604-612.
49. Rodriguez WJ, Khan WN, Cocchetto DM, et al. Treatment of Pseudomonas meningitis with ceftazidime with or without concurrent therapy. Pediatr Infect Dis J. 1990;9:83-87.
50. Saez-Llorens X, Castano E, Garcia R, et al. Prospective randomized comparison of cefepime and cefotaxime for treatment of bacterial meningitis in infants and children. Antimicrob Agents Chemother. 1995;39:937-940.
51. Saez-Llorens X, O'Ryan M. Cefepime in the empiric treatment of meningitis in children. Pediatr Infect Dis J. 2001;20:356-361.
52. Rousseau JM, Soullie B, Villevielle T, et al. Efficacy of cefepime in postoperative meningitis attributable to Enterobacter aerogenes. J Trauma. 2001;50:971.
53. Howard JB, McCracken GH, Trujillo H Jr. Amikacin in newborn infants: comparative pharmacology with kanamycin and clinical efficacy in 45 neonates with bacterial diseases. Antimicrob Agents Chemother. 1976;10:205-210.
54. Sklaver AR, Greenman RL, Hoffman TA. Amikacin therapy of gram-negative bacteremia and meningitis: treatment in diseases due to multiple resistant bacilli. Arch Intern Med. 1978;138:713-716.
55. Trujillo H, Salgado H, Uribe A, et al. Amikacin concentration in the cerebrospinal fluid of children with acute bacterial meningitis. J Int Med Res. 1979;7:45-51.
56. Yogev R, Kolling WM. Intraventricular levels of amikacin after intravenous administration. Antimicrob Agents Chemother. 1981;20(5):583-586.
57. Kaplan SL, Mason EO Jr. Management of infections due to antibiotic resistant Streptococcus pneumoniae. Clin Microbiol Rev. 1998;11:628-644.
58. Kaufman BA. Infections of cerebrospinal fluid shunts. In: Scheld WM, Whitley RJ, Durack DT, eds. Infections of the Central Nervous System. 2nd ed. Philadelphia: Lippincott-Raven; 1997:555-577.
59. Bradley JS, Scheld WM. The challenge of penicillin-resistant Streptococcus pneumoniae meningitis: current antibiotic therapy in the 1990s. Clin Infect Dis. 1997;24:S213-S221.
60. Odio CM, Puig JR, Feris JM, et al. Prospective, randomized, investigator-blinded study of the efficacy and safety of meropenem vs. cefotaxime therapy in bacterial meningitis in children. Pediatr Infect Dis J. 1999;18:581-590.
61. Chin NX, Neu HC. Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria. Antimicrob Agents Chemother. 1984;25:319-326.
62. Hackbarth CJ, Chambers HF, Stella F, et al. Ciprofloxacin in experimental Pseudomonas aeruginosa meningitis in rabbits. J Antimicrob Chemother. 1986;18(suppl D):65-69.
63. Issacs D, Slack MPE, Wilkinson AR, et al. Successful treatment of Pseudomonas ventriculitis with ciprofloxacin. J Antibicrob Chemother. 1986;17:535-538.
64. Millar MR, Bransby-Zachary MA, Tompkins DS, et al. Ciprofloxacin for Pseudomonas aeruginosa meningitis. Lancet. 1986;1:1325.
65. Pioget JC, Wolff M, Singlas E, et al. Diffusion of ofloxacin into cerebrospinal fluid of patients with purulent meningitis or ventriculitis. Antimicrob Agents Chemother. 1989;33(6):933-936.
66. Wolff M, Regnier B, Daldoss C, et al. Penetration of pefloxacin into cerebrospinal fluid of patients with meningitis. Antimicrob Agents Chemother. 1984;26(30):289-291.
67. Bayston R, Barnicoat M, Cudmore RE, et al. The use of intraventricular vancomycin in the treatment of CSF shunt-associated ventriculitis. Z Kinderchir. 1984;39(suppl 2):111-113.
68. Laborada G, Cruz F, Nesin M. Serial cytokine profiles in shunt-related ventriculitis treated with intraventricular vancomycin. Chemotherapy. 2005;51(6):363-365.
69. Pickering LK, Ericsson CD, Ruiz-Palacios G, et al. Intraventricular and parenteral gentamicin therapy for ventriculitis in children. Am J Dis Child. 1978;132(5):480-483.
70. Pfausler B, Haring HP, Kampfl A, et al. Cerebrospinal fluid (CSF) pharmacokinetics of intraventricular vancomycin in patients with staphylococcal ventriculitis associated with external CSF drainage. Clin Infect Dis. 1997;25(3):733-735.
71. Anonymous. Antimicrobial prophylaxis in neurosurgery and after head injury. Infection in Neurosurgery Working Party of the British Society for Antimicrobial Chemotherapy. Lancet. 1994;344:1547-1551.
72. Brown EM. Antimicrobial prophylaxis in neurosurgery. J Antimicrob Chemother. 1993;31(suppl B):49-63.
73. Korinek AM, Golmard JL, Elcheick A, et al. Risk factors for neurosurgical site infections after craniotomy: a critical reappraisal ofantibiotic prophylaxis on 4578 patients. Br J Neurosurg. 2005;19:155-162.
74. Korinek AM, Baugnon T, Golmard JL, et al. Risk factors for adult nosocomial meningitis after craniotomy: role of antibiotic prophylaxis. Neurosurgery. 2006;59:126-133.
75. van Ek B, Dijkmans BA, Van Dulken H. Efficacy of cloxacillin prophylaxis in craniotomy: A one year follow-up study. Scand J Infect Dis. 1991;23:617-623.
76. Alleyne CH Jr, Hassan M, Zabramski JM. The efficacy and cost of prophylactic and periprocedural antibiotics in patients with external ventricular drains. Neurosurgery. 2000;47:1124-1129.
77. Poon WS, Ng S, Wai S. CSF antibiotic prophylaxis for neurosurgical patients with ventriculostomy: a randomised study. Acta Neurochir Suppl. 1998;71:146-148.